Filing Details

Accession Number:
0001384101-24-000181
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-12-04 16:59:39
Reporting Period:
2024-12-02
Accepted Time:
2024-12-04 16:59:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1384101 Veracyte Inc. VCYT Services-Medical Laboratories (8071) 205455398
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1991536 John Leite 6000 Shoreline Court, Suite 300
South San Francisco CA 94080
Chief Commercial Officer-Clia No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-12-02 1,314 $44.12 74,860 No 4 F Direct
Common Stock Disposition 2024-12-03 1,050 $43.25 73,810 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
Footnotes
  1. The reporting person is reporting the withholding of 814 and 500 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,606 and 986 Restricted Stock Units, respectively, granted on September 1, 2022 and March 6, 2023 respectively, and does not represent a sale by the reporting person.
  2. The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 1, 2024.
  3. Represents weighted average sales price. Sale prices for the transactions range from $42.78 to $43.65. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.